Search Results

You are looking at 1 - 10 of 673 items for :

  • interleukin-10 x
Clear All
Open access

Muhammad Sohail Afzal, Shakir Ullah, Zia Ur Rehmann Farooqi, Sadia Anjum, Talha Shafi, Tahir Ahmed, Muhammad Ashraf and Ishtiaq Qadri

interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011; 5:473-9. 8. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun. 2000; 1:185-90. 9. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 1997; 24

Open access

Ingus Skadiņš, Juta Kroiča, Ilze Salma, Aigars Reinis, Marina Sokolova and Dagnija Rostoka

, 63–75. McCann, M. T., Gilmore, B. F., Gorman, S. P. (2008). Staphylococcus epidermidis device-related infections: Pathogenesis and clinical management. JPP , 60 , 1551–1571. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., O’Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. , 19 , 683–765. Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., Banchereau, J. (1992). Interleukin 10 is a potent growth and differentiation factor for activated human B

Open access

M. Zuśka-Prot, T. Maślanka, A. Jasiecka and J. J. Jaroszewski

-10 and IL-12 synthesis. J Immunol 164: 361-370. van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA (1995) Prostaglandin E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181: 775-779. Wang MT, Honn KV, Nie D (2007) Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26: 525-534.

Open access

Zsuzsánna Réti, Iz Kun and Corina Cristina Radu Pop

characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol. 2003;148(5):491-5. 10. Dolman PJ. Evaluating Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012;26(3):229-48. 11. Gerding MN, van der Meer JW, Broenink M, et al. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf). 2000;52(3):267-71. 12. Eckstein AK, Johnson KT, Thanos M, Esser J, Ludgate M

Open access

Mahmoud Orazizadeh, Maryam Yadegari, Mahmoud Hashemitabar and Ali Khodadadi

cartilage explants. Turk J Vet Anim Sci. 2005; 29:951-7. 9. Yeh LA, Augustine AJ, Lee P, Riviere LR, Sheldon A. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J Rheumatol. 1995; 22:1740-6. 10. Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegard D, van den Berg WB. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen induced arthritis. Arthritis Res. 1999; 1:81-91. 11. Cleaver CS, Rowan AD

Open access

Joanna Orlowska, Urszula Kurczewska, Katarzyna Derwinska, Wojciech Orlowski and Daria Orszulak-Michalak

nonwovens for medical end-uses. In: Cusick GE, ed. Nonwoven Conference Papers, UMIST 1983 6. Eberlein T., et al; Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised or locally infected wounds, J Wound Care, 21, 1, 2012. 7. Eming SA., et al.; Accelerated wound closure in mice deficient for interleukin-10, J.Pathol. 170.1, 2007. 8. Gallin J. I., et al.; Inflammation: Basic Principles and Clinical Correlates, New York Raven, 1999 2nd ed. 9. Gallucci RM., et al

Open access

Raluca Elena Tripon, Ioana Berindan Neagoe, Livia Budisan, Tudor Lucian Pop, Victor Cristea, Liana Maria Stanca and Mihaela Sorina Lupse

diagnosis and management of community-acquired pneumonia. Crit Care 2010;14(1):203. DOI: 10.1186/cc8155 20. Vasconcellos Â, Clarêncio J, Andrade D, Cardoso MA, Barral A, Nascimento-Carvalho CM. Systemic cytokines and chemokines on admission of children hospitalized with community-acquired pneumonia. Cytokine 2018;107:1-8. DOI: 10.1016/j.cyto.2017.11.005 21. Khattab A, El-Mekkawy M, Shehata A, Whdan N. Clinical study of serum interleukin-6 in children with community-acquired pneumonia. Gaz Egypt Paediatr Assoc 2018;66(2):43-48. DOI: 10.1016/j.epag.2018

Open access

Ting Miao

Exp Med, 1998, 187(4):619-29. 20 Laleh M, Richard LM, Claude L. Regulatory B and T cells in infections. Mic Infec, 2008, 10(9):1030-5. 21 Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin 10production by B220+cells from schistosome-infected mice: a mechanism for regulation of CD4+T-cell subsets. Proc Nat Acad Sci U S A, 1994, 91(1):18-22. 22 Velupillai P, Secor WE, Horauf AM, et al . B-1cell(CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J

Open access

Irena Kostic, Marko Spasic, Bojan Stojanovic, Milena Jurisevic, Dragce Radovanovic, Dragan Canović, Srdjan Stefanovic and Slobodan Jankovic

. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Resp Crit Care Med 2002; 166: 1475-1482 18. Smith JW, Gamelli RL, Jones SB, Shankar R. Immunologic responses to critical injury and sepsis. J Intensive Care Med 2006; 21: 161-172

Open access

Hiromichi Ohtsuka, Maki Inoue, Yosuke Maeda, Taishi Tanabe and Motoshi Tajima

Black and Holstein calves. Anim Sci J 2011, 82:93-98. 8. Nagahata H, Kojima N, Higashitani J, Ogawa H, Noda H. Postnatal changes in lymphocyte function of dairy calves. Zentralbl Veterinarmed B 1991, 38:49-54. 9. DeBey BM, Roth JA, Brogden KA, Cutlip RC, Stevens MG, Jones T, Briggs RE, Kluge JP. In vitro lymphocyte proliferative responses and gamma-interferon production as measures of cell-mediated immunity of cattle exposed to Pasteurella haemolytica. Can J Vet Res 1996, 60:263-270. 10. Jacks S, Giguère S, Crawford PC, Castleman WL. Experimental